SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
IMMUNIC held its annual stockholder meeting and disclosed final voting results, including election of three Class III Directors (Michael Bonney, Thorvald Nagel, and Richard Rudick), approval of an amendment to the 2019 Omnibus Equity Incentive Plan increasing authorized shares by 6,000,000, and ratification of Baker Tilly as independent auditor.
View raw filing on EDGAR →The exhibit is a shareholder letter dated June 29, 2026, following the Company's Annual General Meeting on June 26, 2026. It explicitly references the AGM vote ("Your vote is not something we take for granted") and reports the Board's mandate and plans to expand independent director representation. While the letter also contains forward-looking strategic commentary, the core disclosure is the AGM outcome and the Board's response, which constitutes shareholder vote results under Item 5.07 equivalent for a foreign private issuer.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from AleAnna's June 26, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports the voting outcomes for two proposals: election of Class II directors (Curtis Hébert Jr. and William K. Dirks) and ratification of Deloitte & Touche LLP as independent auditor, with detailed vote tallies showing both proposals were approved. This is a routine but material governance disclosure required by Item 5.07.
View raw filing on EDGAR →The filing discloses results of the 2026 annual meeting of stockholders held on June 29, 2026, with detailed voting tallies for five proposals including director elections, auditor ratification, equity plan amendment, warrant issuance authorization, and reverse stock split approval. Item 5.07 explicitly presents voting results with vote counts for each proposal, which is the defining characteristic of shareholder_vote_results. The equity plan amendment and warrant issuance approvals are material governance and capital structure decisions requiring shareholder authorization.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of an extraordinary general meeting of CEPT shareholders held on June 29, 2026, where shareholders voted on four major proposals including approval of a Business Combination Agreement with Securitize, Inc., the CEPT Merger, organizational documents for the post-merger entity (PubCo), and Nasdaq Rule 5635 compliance. All proposals received requisite shareholder approval, with Proposal 1 (Business Combination) receiving 12,432,037 votes for, 2,151,147 against, and 197,157 abstentions. The filing explicitly states that "In light of receipt of the requisite approvals by CEPT Shareholders described above, CEPT expects the Business Combination to be completed promptly," confirming this is a material shareholder vote result that clears the path for a transformative M&A transaction.
View raw filing on EDGAR →The 6-K discloses results of an Extraordinary General Meeting of Shareholders held on June 29, 2026, where shareholders approved four material resolutions: (1) acquisition of 80–100% of Psyga Bio Ltd. via private placement of shares and warrants; (2) private placement of up to $1.5M from specified investors; (3) increase of authorized share capital by 2.9B shares; and (4) appointment of auditors. This is a classic shareholder vote results disclosure under Item 5.07 equivalent, and the underlying transactions (M&A, dilutive issuance, auditor appointment) are material to investors.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from a reconvened annual meeting held on June 23, 2026. The filing reports the outcomes of two proposals: (1) election of Ronald J. Kramer and Leslie D. Michelson as Class III directors, with specific vote tallies (For/Against/Abstain), and (2) stockholder approval to authorize sales of Common Stock below net asset value, with detailed voting results. This directly matches the shareholder_vote_results event type and Item 5.07 disclosure requirement.
View raw filing on EDGAR →Western Uranium & Vanadium held its Annual General and Special Meeting of Shareholders on June 26, 2026, with shareholder approval of director re-elections (George Glasier, Bryan Murphy, Andrew Wilder, Michael Skutezky), reappointment of MNP LLP as auditor, and reapproval of the 2023 Incentive Stock Option Plan and 2023 Shareholder Rights Plan.
View raw filing on EDGAR →The filing discloses results of a special meeting of stockholders held on June 24, 2026, where three proposals were voted on and approved: (i) approval of issuance of shares upon exercise of restricted common stock purchase warrants from the February 2026 Private Placement; (ii) approval of issuance of shares upon conversion of Series B Convertible Preferred Stock; and (iii) authorization for the Board to effect a reverse stock split at a ratio between one-for-two and one-for-two hundred fifty. This is a classic Item 5.07 shareholder vote results disclosure with material implications for capital structure and dilution.
View raw filing on EDGAR →Quantum Computing Inc. held its Annual Meeting on June 24, 2026, with shareholders voting on five proposals: election of six directors, advisory vote on named executive officer compensation, ratification of independent auditor BPM LLP, approval of a Certificate of Incorporation amendment increasing authorized shares from 260 million to 460 million, and approval of an amendment to the 2022 Equity and Incentive Plan increasing authorized shares from 20 million to 30 million and modifying the evergreen provision.
View raw filing on EDGAR →The 6-K furnishes a consolidated synthetic remote voting map for an Extraordinary General Meeting held on June 30, 2026, disclosing voting results on six resolutions. The core resolutions (Items 1–5) concern approval of a merger of Esfera Fidelidade S.A. into Banco Santander (Brasil), including ratification of the appraiser (PricewaterhouseCoopers), approval of the appraisal report, and approval of the merger protocol and transaction itself. These are material M&A-related shareholder votes with overwhelming approval (59+ million votes for on common shares). The disclosure is a post-vote reporting of shareholder approval results, fitting the shareholder_vote_results category under Item 5.07 equivalent.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Niagen Bioscience's 2026 Annual Meeting of Stockholders, including voting outcomes for three proposals: election of eight directors, ratification of Crowe LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents vote tallies (For, Against, Abstain, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →NRC Health held its Annual Meeting of Stockholders on June 23, 2026, with shareholders voting on six proposals: election of seven directors, ratification of KPMG LLP as auditor, an advisory vote on named executive officer compensation, and three amendments to the certificate of incorporation. The detailed voting results for each proposal are disclosed.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of the Company's Annual Meeting of Stockholders held on June 24, 2026, including voting outcomes on three proposals: election of five directors, advisory approval of named executive officer compensation, and ratification of PwC as independent auditor. The filing presents vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, confirming all three passed with substantial majorities. This is a textbook shareholder_vote_results disclosure.
View raw filing on EDGAR →The filing's primary content is Item 5.07, which discloses the results of the Annual Meeting of Stockholders held on June 26, 2026. The filing presents detailed voting results on five matters: election of nine directors, amendment to the 2022 Equity Incentive Plan, advisory vote on named executive officer compensation, and ratification of Deloitte & Touche as independent auditors. While Item 8.01 also discloses a 5% stock dividend declaration, the substantive focus and Item designation center on shareholder vote results, which is material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →The 6-K discloses the results of Robot Consulting Co., Ltd.'s Annual General Meeting of Shareholders held on June 26, 2026, with detailed voting tallies for all four proposals (approval of financial statements, election of statutory auditor, capital reduction and surplus disposition, and articles amendment). This is a classic shareholder_vote_results disclosure. The materiality is high because the proposals include capital reduction and articles amendment, which are structural changes affecting shareholders' interests.
View raw filing on EDGAR →This 8-K discloses Item 5.07 results from Orion S.A.'s Annual General Meeting of Shareholders held on June 25, 2026. The filing presents detailed voting results on 11 proposals, including director elections (Proposals 1(i)–1(viii)), board compensation approval (Proposal 2), say-on-pay votes (Proposals 3–4), financial statement approvals (Proposals 5–6), dividend allocation (Proposal 7), board and auditor discharge (Proposals 8–9), and auditor appointments (Proposals 10–11). All matters were approved by shareholders, making this a standard shareholder vote results disclosure material to investors' understanding of governance and capital allocation decisions.
View raw filing on EDGAR →The filing discloses Item 5.07 — submission of matters to a vote of security holders. On June 24, 2026, majority stockholders (collectively holding 95.3% of voting power) delivered written consent approving an amendment to the Company's Certificate of Incorporation to eliminate voting rights of Class E Common Stock except as required by law. This is a material shareholder action that fundamentally alters the capital structure and voting rights of the Company's security holders.
View raw filing on EDGAR →The filing discloses results of a special stockholder meeting held on June 26, 2026, where shareholders voted to approve two Warrant Inducement Agreements dated March 15, 2026 and April 26, 2026. Item 5.07 explicitly presents voting tallies (FOR, AGAINST, ABSTAIN) for both proposals, with both warrant agreements approved by substantial majorities. The approval satisfies the stockholder approval condition required under Nasdaq listing rules, permitting exercise of the new Series A-5 and Series A-6 warrants, which is material to investors assessing potential dilution and capital structure changes.
View raw filing on EDGAR →The 6-K discloses results of an extraordinary general meeting held on June 29, 2026, where shareholders voted on five resolutions. The primary resolutions approved include: (1) increasing authorized share capital from US$500,000 to US$23,000,000 (Resolution 1A, 98.07% FOR); (2) adopting amended articles of association to reflect the capital increase (Resolution 1B, 98.06% FOR); (3) authorizing the board to implement share consolidations at a 2:1 to 500:1 ratio within one year (Resolution 2, 98.07% FOR); and (4) authorizing further amended articles to reflect any consolidation (Resolution 3, 98.44% FOR). All resolutions passed with substantial majorities. This is a classic shareholder vote results disclosure under Item 5.07 equivalent, material to investors as it authorizes significant capital structure changes.
View raw filing on EDGAR →Criteo held its 2026 Annual Combined General Meeting of Shareholders on June 29, 2026, with voting results on 22 resolutions including director reelections, executive compensation approval, financial statement approval, share buyback authorizations, equity grants, and bylaw amendments.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Kaltura's June 24, 2026 Annual Meeting of Stockholders. The filing reports the vote tallies for two proposals: election of two Class II directors (Richard Levandov and Ronen Faier) and ratification of the independent auditor (Kost Forer Gabbay & Kasierer). Both proposals passed with disclosed vote counts, which is the core content of Item 5.07 shareholder vote results.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from vTv Therapeutics' 2026 Annual Meeting of Stockholders held on June 26, 2026. The filing reports voting outcomes on three matters: (1) election of seven director nominees to the Board, (2) ratification of Ernst & Young LLP as independent auditor, and (3) nonbinding advisory vote on named executive officer compensation. This is a textbook Item 5.07 disclosure and is material to investors as it reflects governance decisions and board composition.
View raw filing on EDGAR →This exhibit discloses the voting results from trivago N.V.'s Annual General Meeting of Shareholders held on June 26, 2026, presenting tabulated results for ten resolutions including adoption of annual accounts, appointment of external auditor, re-appointment of managing and supervisory directors, and approval of equity plan amendments. The disclosure directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Liberty Latin America's Annual General Meeting held on June 23, 2026. The filing reports final certified voting outcomes on three proposals: election of four Class III directors, appointment of KPMG LLP as independent auditor, and approval of the 2026 Incentive Plan. The detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, BROKER NON-VOTES) for each proposal are the hallmark of Item 5.07 shareholder vote disclosures, and the results confirm approval of all three matters.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the 2026 Annual General Meeting held on June 29, 2026. The filing reports the outcomes of six ordinary resolutions, including adoption of annual accounts, approval of directors' remuneration, auditor appointment (Ernst & Young LLP), and re-election of three directors (M Bonney, E Leiderman, and RW Azelby), with vote tallies for each resolution. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects shareholder governance decisions and approval of key corporate matters.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of UiPath's annual meeting of stockholders held on June 25, 2026. The filing presents voting results for three proposals: election of seven directors, a non-binding say-on-pay vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals were approved by stockholders with strong majorities, and the disclosure includes detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, and BROKER NON-VOTE) for each proposal.
View raw filing on EDGAR →Stockholders of Rhinebeck Bancorp and depositors of Rhinebeck Bank approved the Amended and Restated Plan of Conversion and Reorganization at special meetings held on June 29, 2026, converting Rhinebeck Bancorp, MHC from a mutual holding company to a fully public stock holding company structure, with 10,108,446 votes in favor and 7,369 against.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Tarsus Pharmaceuticals' Annual Meeting of Stockholders held on June 25, 2026. The filing reports voting outcomes on three proposals: election of four Class III directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with substantial majorities. This is a routine but material governance disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →The 8-K discloses notice of Paramount's 2026 annual meeting of stockholders scheduled for July 21, 2026, where stockholders will vote on director elections and auditor ratification. While the filing indicates that Harbor Lights (holding 100% of Class A voting stock) has already indicated intent to approve both proposals by written consent prior to the meeting, the disclosure is fundamentally about pending stockholder voting matters and the mechanism for their approval. This is most closely aligned with shareholder_vote_results, as the filing announces the meeting and expected voting outcomes, though technically the results are pre-determined by written consent rather than a traditional vote at the meeting.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Oxford Industries' 2026 Annual Meeting of Shareholders held on June 23, 2026. The filing reports voting outcomes on four proposals: election of three Class I directors (Dennis M. Love, Clyde C. Tuggle, and Carol B. Yancey), approval of the Long-Term Stock Incentive Plan with 750,000 additional shares, selection of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All proposals passed with substantial majorities, making this a material governance disclosure that affects investor understanding of board composition and corporate governance.
View raw filing on EDGAR →This is a voting results report filed pursuant to National Instrument 51-102 disclosing the outcomes of Trekor Metals Limited's annual general meeting held on June 24, 2026. The exhibit presents detailed voting tallies for six items: auditor appointment (99.43% in favor), director count (98.70% in favor), election of nine directors (ranging from 73.8% to 99.2% in favor), name change approval (95.57% in favor), plan amendments (70.16% in favor), and say-on-pay advisory vote (96.20% in favor). This is a classic shareholder_vote_results disclosure documenting the formal outcomes of shareholder votes at an annual meeting.
View raw filing on EDGAR →Energy Fuels Inc. held its 2026 annual meeting of shareholders on June 24, 2026, with voting results reported on four proposals: election of seven directors, appointment of KPMG LLP as auditors, a Say-on-Pay advisory vote, and a Say-When-On-Pay advisory vote.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the final voting results from SmartKem's Annual Meeting of Stockholders held on June 23, 2026. The filing presents detailed vote tallies for all eleven proposals submitted to shareholders, including director elections, executive compensation advisory votes, auditor ratification, and multiple charter amendments. The disclosure of shareholder vote results is material as it reflects stockholder approval of significant corporate actions including authorization increases and governance changes.
View raw filing on EDGAR →The exhibit announces voting results from H World's 2026 Annual General Meeting held on June 26, 2026. It discloses passage of four ordinary resolutions: ratification of Deloitte as auditor, re-election of Justin Martin Leverenz as director, re-election of Yi Zhang as independent director and audit committee chairwoman, and authorization for implementation actions. This is a classic shareholder_vote_results disclosure reporting outcomes of an annual meeting vote.
View raw filing on EDGAR →This exhibit discloses the poll results of Hesai Group's Annual General Meeting held on June 26, 2026, including voting outcomes on seven ordinary resolutions covering financial statement adoption, director re-elections, auditor re-appointment, share issuance and repurchase mandates, and a material share subdivision (8-for-1 split effective July 10, 2026). The detailed voting tallies by share class and the passage of all resolutions constitute a shareholder_vote_results disclosure. The share subdivision is material to investors as it affects share structure and trading arrangements.
View raw filing on EDGAR →Celldex held its Annual Meeting of Stockholders on June 25, 2026, with shareholders voting on four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, approval of an amendment to the 2021 Omnibus Equity Incentive Plan increasing available shares by 3.4 million, and advisory approval of named executive officer compensation. All proposals received tabulated voting results.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of CION's Annual Meeting of Shareholders held on June 25, 2026, including voting outcomes for two proposals: election of two board directors (Robert A. Breakstone and Catherine K. Choi) and ratification of RSM US LLP as independent auditor. The filing provides detailed vote tallies (votes for, withheld, against, abstentions, and broker non-votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →The filing discloses the convening and adjournment of an extraordinary general meeting on June 26, 2026, where shareholders voted to approve an adjournment of the meeting to allow for a reconvened vote on a proposal to extend the date by which the Company must consummate an initial business combination. While the final vote on the Extension itself has not yet occurred (scheduled for the reconvened meeting at 3:00 p.m. the same day), the disclosure of the shareholders' approval of the adjournment proposal constitutes a shareholder vote result material to investors assessing the Company's timeline for completing its business combination.
View raw filing on EDGAR →Kroger held its 2026 Annual Meeting of Shareholders on June 25, 2026, with shareholders voting on director elections (ten directors elected), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the Second Amended and Restated 2019 Long-Term Incentive Plan, and rejection of a shareholder proposal on GHG emissions reductions.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Navitas Semiconductor's 2026 annual meeting of stockholders held on June 25, 2026, including voting outcomes on four proposals: election of three directors, declassification of the board (which failed), advisory approval of executive compensation, and ratification of KPMG LLP as auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →The 6-K discloses the results of Polestar's 2026 annual general meeting held on June 26, 2026, including voting outcomes on 16 resolutions covering financial statement approval, director re-appointments, auditor appointment (PwC replacing Deloitte AB), remuneration policies, and share issuance authorities. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, with detailed vote tallies and outcomes. The auditor change (Deloitte AB to PwC) is material but is disclosed as part of the AGM voting results rather than as a standalone auditor_change event.
View raw filing on EDGAR →Shareholders of SELECT MEDICAL HOLDINGS CORP voted on June 26, 2026 to approve the Merger Proposal to adopt the Agreement and Plan of Merger with Stallion Intermediate Corporation and Stallion MergerSub Corporation, with 99,005,011 votes in favor and 1,789,017 against, representing approval by over 79.88% of outstanding shares and over 76.64% of unaffiliated shares. The vote also addressed a non-binding advisory Compensation Proposal (52,322,733 for, 48,410,193 against) and an Adjournment Proposal (rendered moot).
View raw filing on EDGAR →Shareholders approved two proposals at a meeting held on June 26, 2026: (i) an Extension Amendment extending the initial business combination deadline from June 27, 2026 to September 27, 2026, with further discretionary extensions possible, and (ii) an Adjournment Proposal. The Extension Amendment received 21,123,642 votes in favor and 1,619,105 votes against.
View raw filing on EDGAR →The 6-K discloses results of GH Research PLC's annual general meeting held on June 25, 2026, where shareholders voted on and passed all board-recommended resolutions, including re-election of four directors (Florian Schönharting, Michael Forer, Dermot Hanley, and Duncan Moore) and ratification of PricewaterhouseCoopers Ireland as independent auditors. This is a classic shareholder vote result disclosure under Item 5.07 equivalent for foreign private issuers.
View raw filing on EDGAR →BridgeBio held its Annual Meeting on June 22, 2026, with shareholders voting on five proposals: election of three Class I directors (James C. Momtazee, Frank P. McCormick, and Hannah A. Valantine), advisory approval of named executive officer compensation, annual frequency of say-on-pay votes, ratification of Deloitte & Touche LLP as independent auditor, and approval of an amendment to the 2021 Stock Option and Incentive Plan increasing reserved shares by 2,000,000.
View raw filing on EDGAR →AES shareholders voted on June 26, 2026 at a special meeting to approve the proposed acquisition by a consortium led by Global Infrastructure Partners and EQT, with the merger proposal passing with 97.92% of votes cast in favor (479,072,642 votes). The transaction is valued at approximately $10.7 billion in equity value and $33.4 billion enterprise value, and the HSR Act waiting period expired on June 22, 2026, clearing a major regulatory condition for the acquisition.
View raw filing on EDGAR →The exhibit is a press release announcing the results of Highlander Silver's annual general meeting of shareholders held on June 25, 2026. It discloses the approval of all matters presented, including the election of six directors and re-appointment of auditors, with detailed voting results for each director nominee. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and is material as it confirms the composition of the board of directors.
View raw filing on EDGAR →This press release discloses the voting results from Fury Gold Mines' Annual General Meeting held on June 25, 2026, including shareholder approval of: (1) fixing the board at six directors; (2) election of all six director nominees; (3) appointment of PricewaterhouseCoopers LLP as auditor; and (4) renewal of the long-term incentive plan for three years. The disclosure directly matches the `shareholder_vote_results` taxonomy entry, which covers results of votes at annual or special meetings of security holders. Board elections and auditor appointments are material governance matters affecting investor assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →This press release announces the results of Titan Mining's annual shareholders' meeting held on June 25, 2026. It discloses the approval of three matters: setting the board size at seven directors, election of all seven director nominees (with detailed voting results for each), and re-appointment of Ernst & Young LLP as auditors. The detailed vote tallies for each director nominee are the core disclosure, matching the shareholder_vote_results category precisely.
View raw filing on EDGAR →